Whole–genome characterization of chemoresistant ovarian cancerAnn‐Marie Patch, Suzanne Manning, Stephen Cordner et al.|Nature|2015Cited by 1.7k
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical OutcomeRichard W. Tothill, David D.L. Bowtell, Anna V. Tinker et al.|Clinical Cancer Research|2008Cited by 1.5k
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian CancerEllen L. Goode, Naveena Singh, Matthew S. Block et al.|JAMA Oncology|2017Cited by 409
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinomaOlga Kondrashova, L. Green, Monique Topp et al.|Nature Communications|2018Cited by 299
Prognostic gene expression signature for high-grade serous ovarian cancerJoshua Millstein, Scott D. Brown, Timothy Budden et al.|Annals of Oncology|2020Cited by 173